PIPA146127

Kallikrein 11 Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA146127-Each-of-1 In Stock ₹ 46,502.50

PIPA146127 - Each of 1

₹ 46,502.50

In Stock

Quantity

1

Base Price: ₹ 46,502.50

GST (18%): ₹ 8,370.45

Total Price: ₹ 54,872.95

Antigen

Kallikrein 11

Classification

Polyclonal

Conjugate

Unconjugated

Gene

Klk11

Gene Alias

2310015I08Rik; Hippostasin; hK11; kallikrein 11; kallikrein related peptidase 11; kallikrein related-peptidase 11; Kallikrein11; kallikrein-11; Kallikrein-11 inactive chain 1; Kallikrein-11 inactive chain 2; kallikrein-related peptidase 11; KLK11; protease, serine, 20; Prss20; Serine protease 20; TLSP; Trypsin-like protease; UNQ649/PRO1279

Host Species

Rabbit

Purification Method

Antigen affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

11012

Content And Storage

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Form

Liquid

Applications

Western Blot

Concentration

1 mg/mL

Formulation

PBS with 0.02% sodium azide

Gene Accession No.

Q9UBX7

Gene Symbols

Klk11

Immunogen

Residues 68-82 of the 35 kDa human hippostasin/Kallikrein 11protein.

Quantity

100 μL

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG

Related Products

Img

Thermo Scientific

PIPA123459

--

Img

Thermo Scientific

PIPA146133

--

Img

Thermo Scientific

PIPA121872

--

Img

Thermo Scientific

PIPA146312

--

Img

Thermo Scientific

PIPA129027

--

Img

Thermo Scientific

PIPA146143

--

Img

Thermo Scientific

PIPA146237

--

Img

Thermo Scientific

PIPA125307

--

Description

  • Hippostasin, also known as KLK11, is a kallikrein-like serine protease, which has two alternatively spliced isoforms, brain-type and prostate-type
  • Hippostasin plays a role in the prostate, including reproductive and/or tumorigenic functions
  • Elevated serum levels of KLK11 were found in 70% of women with ovarian cancer and in 60% of men with prostate cancer
  • Analysis of the KLK11 biomarker in serum may aid in the diagnosis and monitoring of ovarian and prostatic carcinoma.